The impact of zinc supplement on treatment of pneumonia

Phase 2

• Conditions: Pneumonia.; Pneumonia, organism unspecifide

• Registration Number: IRCT138810303122N1
• Lead Sponsor: Vice Chancellor for research of Jundishapur university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 128

Inclusion Criteria

1) age of 3 to 60 mo, 2) Clinical diagnosis of pneumonia: a) Tachypnea: > 45 in 3-6mo, >40 in 6-12mo, >30 in 13-36mo, >25 in 37-60mo b) Fever: >38.5 Rectal c) Respiratory distress: Nasal flaring, intercostals retraction, Central cyanosis d) Rales in chest auscultation e) Infiltration in Chest X ray, 3) Parents satisfaction, 4) The ability of child to drink the drug and placebo
Exclusion criteria: 1) Malnutrition, 2) Additional systemic disease (meningitis, sepsis), 3) Diarrhea (> 3 time watery defecations), 4) Allergy to zinc supplements, 5) Severe respiratory disease, family history of asthma, congenital heart disease, 6) Chest wheezing in physical examination, 7) History of recently using antibiotic

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified